Clinical Trials Browser

OTHER × Prostatic Hyperplasia × Dutasteride × Clear all

NCT00706966 2014-01-17

MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer

Phase NA Completed

10 enrolled 14 charts

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms